B-100 complex can interfere with other medicines including but not limited to: levodopa, medicines containing oestrogen, hydrazine, certain anti epileptic drugs, phenobaritone, phenytoin, immunosuppressants and some drugs used to treat infections such as isoniazid, pyrazinamide, cycloserne and penicillamine
Federal agencies have effectively pulled BPC-157 out of legal circulation, citing the very uncertainties that should give patients and doctors pause
For those with a temporary deficiency or improved dietary intake, our providers may recommend switching to oral supplements or eventually discontinuing injections altogetheralways under careful medical supervision
Thank you all the authors Julie Munsoor, Christopher Wu, Yongsu Kwon To view or add a comment, sign in Exosomes and Peptides are not only products
BPC-157, short for Body Protection Compound-157, is a derivative of body protection compound (BPC)